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ABSTRACT
Background    High resolution melting (HRM) is a post-
PCR technique for variant screening and genotyping 
based on the different melting points of DNA fragments. 
The advantages of this technique are that it is fast, sim-
ple, and efficient and has a high output, particularly for 
screening of a large number of samples. APOA1 encodes 
apolipoprotein A1 (apoA1) which is a major compo-
nent of high density lipoprotein cholesterol (HDL-C). 
This study aimed to obtain an optimal quantitative 
polymerase chain reaction (qPCR)-HRM condition for 
screening of APOA1 variance.
Methods    Genomic DNA was isolated from a periph-
eral blood sample using the salting out method. APOA1 
was amplified using the RotorGeneQ 5Plex HRM. The 
PCR product was visualized with the HRM amplifica-
tion curve and confirmed using gel electrophoresis. The 
melting profile was confirmed by looking at the melting 
curve. 
Results    Five sets of primers covering the translated re-
gion of APOA1 exons were designed with expected PCR 
product size of 100–400 bps. The amplified segments of 
DNA were amplicons 2, 3, 4A, 4B, and 4C. Amplicons 
2, 3 and 4B were optimized at an annealing temperature 
of 60 °C at 40 PCR cycles. Amplicon 4A was optimized 
at an annealing temperature of 62 °C at 45 PCR cycles. 
Amplicon 4C was optimized at an annealing tempera-
ture of 63 °C at 50 PCR cycles.
Conclusion    In addition to the suitable procedures of 
DNA isolation and quantification, primer design and 
an estimated PCR product size, the data of this study 
showed that appropriate annealing temperature and PCR 
cycles were important factors in optimization of HRM 
technique for variant screening in APOA1.
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High resolution melting (HRM) is a post-PCR tech-
nique for variant screening and genotyping based on 
different melting points of DNA fragments.1 The main 
principle of HRM is the integration of intercalating dye 
to double stranded DNA (dsDNA) and disintegration 
of the fluorescence dye when the dsDNA are separated 
to single stranded DNA (ssDNA). By using a real time 
measurement of the fluorescence level, a melting curve 
of fluorescence level against time is formed. The melt-
ing profile is mainly influenced by the length of DNA 
fragment, the GC content and heterozygosity.1–3 Thus, 
the advantages of this technique are that it is fast, sim-
ple, efficient and high throughput result, particularly for 
screening of a large number of samples.1, 3, 4
 APOA1 is located in chromosome 11q23 and en-
codes apolipoprotein A1 (apoA1). APOA1 spans about 
2.2 kb and contains 4 exons.6 ApoA1 composes up to 
70% of HDL-C.7 In the structure of HDL, apoA1 is a 
group of proteins arranged in an anti-parallel double-belt 
structure.8 It is a cofactor for lecithin cholesterolacyl 
transferase (LCAT), substrate for scavenger receptor 
class B member 1 (SR-B1).9 Deletions in the APOA1 
result in a decrease of HDL-C level to less than 40 mg/
dL.10 The monogenic disorder caused by APOA1 muta-
tion comprises about less than 5% of low HDL-C level 
cases,11 but it accelerates the atherosclerosis process in 
contrast to other mutations in genes which encode the 
main protein of reverse cholesterol transport (RCT).12 
 This study aimed to obtain an optimal quantitative 
polymerase chain reaction (qPCR)-HRM condition for 
screening of APOA1 variance. So far, it is the first study 
which screens variance in APOA1 using HRM tech-
nique; therefore optimization of the technique is very 
25
HRM technique for APOA1 variance screening
important in order to get a reliable result.13 In addition to 
a suitable procedure for DNA isolation and quantifica-
tion, primer design and an estimated PCR product size, 
this study found that appropriate annealing temperature 
and PCR cycles were important factors in optimization 
of HRM technique for variant screening in APOA1.
MATERIALS AND METHODS
Primer design 
The first step in this study was designing primers for 
APOA1. The referent sequences were taken from the 
database of UCSC Genome Bioinformatics Human Ge-
nome Browser Gateway (http://genome.ucsc.edu/cgi-bin/
hgGateway?redirect=manual&source=genome.ucsc.edu) 
and Ensembl (www.ensembl.org) with the accession 
numbers were GRCh38/hg3814 and ENSG00000118137,6 
respectively. The primers were designed with PCR 
product sizes 100–400 bps using the Lightcycler Primer 
Design Software V.1.0.R.84 (Idaho Tech, Salt Lake City, 
UT). The concentration of primers both forward and re-
verse primers was 10 pmol/μL.
 Based on the gene sequence database, the primers 
were designed from the start codon at exon 2. Exon 1 is 
an untranslated region, and thus it was not included in 
the analysis. The primers for amplicon 2 and amplicon 
3 have a PCR product size of less than 250 bps as an 
ideal. They were located in intron with the purpose of 
covering the entire exon area. Exon 4 was divided into 3 
amplicons, i.e. 4A, 4B and 4C in order to get optimum 
HRM results. The details are listed in Table 1. The 
primers were designed to cover all exons from 2 to 4 and 
their flanking regions.
DNA isolation and quantification
The genomic DNA was isolated using the salting out 
method. Then, the DNA concentration was quantified 
using the Nanovue Plus (GE Healthcare Bio Sciences 
AB, Buckinghamshire, UK). The DNA samples were 
diluted using distilled water to a concentration of 10 ng/
μL. The genomic DNA from normal healthy donors was 
used in the optimization of qPCR-HRM. The criteria of 
normal healthy donors were that their HDL-C level > 40 
mg/dL, cholesterol total level < 200 mg/dL, LDL-C level 
< 160 mg/dL, triglyceride level < 150 mg/dL, and their 
DNA sequence were similar to the reference sequence in 
the NCBI database. Informed consent for participation in 
this study was obtained. The investigation was approved 
by the Institutional Review Board of the Diponegoro 
University Faculty of Medicine and Dr. Kariadi Hospital 
(number 190/EC/FK/RSDK/2013) and conformed to the 
principles outlined in the Declaration of Helsinki.15 
HRM technique and its data analysis
APOA1 was amplified using qPCR RotorGeneQ 5Plex 
HRM (Qiagen, Valencia, CA) with total volume 10 µL 
in each tube. Each tube consisted of 5 μL Type-It HRM 
Master Mix (Qiagen, Cat. No. 206542), 1 μL of forward 
and reverse primers each with a concentration of 10 
pmol/μL, 2 μL of DNA with a concentration of 10 ng/
μL and 2 μL of  H2O. The curve analysis was done with 
Table 1. List of primers, nucleotide positions, PCR products size and their GC content
Exon Amplicon Primer Sequences Nucleotide Positions Primer GC content (%)
Product 
size (bp)
Amplicon GC 
content (%)
2 2 F: GCCAGGCCCTTCTTCTC
GRCh38/hg38: chr11: 
116836271-116836287 64.7 116 59.0
R: 
GGTTGGCTCCCTAGGTT 
GRCh38/hg38: chr11: 
116836370-116836386 58.8
3 3 F: GGCCTGATCTGGGTCTC 
GRCh38/hg38: chr11: 
116836512-116836528 64.7 246 58.6
R: 
TCATCCCACAGGCCTCT 
GRCh38/hg38: chr11: 
116836741-116836757 58.8
4 4A F: CCAGCCCTCAACCCTTC 
GRCh38/hg38: chr11: 
116837258-116837274 64.7 290 60.3
R: 
CCCTCTTGGAGCTCTGC 
GRCh38/hg38: chr11: 
116837531-116837547 58.8
4 4B F:GCAGGAGGAGATGGAGCTCTA 
GRCh38/hg38: chr11: 
116837485-116837505 57.1 327 69.7
R: 
CCTTGGCGGAGGTCCTC 
GRCh38/hg38: chr11: 
116837795-116837811 64.7
4 4C F: TCAGCGAGAAGGCCAAG 
GRCh38/hg38: chr11: 
116837769-116837785 58.8 273 63.4
R: 
AGGAAGTCCCTGCTCCA 
GRCh38/hg38: chr11: 
116838025-116838041 58.8
bp, base pair; F, forward primer; R, reverse primer; GC, guanine and cytosine.
26
H. Wahyuningsih et al.
Rotor Gene–Pure Detection version 2.1.0 (build 9) Soft-
ware (Qiagen). The PCR product was visualized with 
the amplifi cation curve and confi rmed with1.5% agarose 
gel for 30 minutes. The melting profile was analyzed 
through melting curve. 
RESULTS
Optimization of APOA1 was done in exon 2 to 4 which 
were divided into 5 amplicons. They were amplified 
by using 5 pairs of primers. Because of its length, exon 
4 was divided into 3 amplicons, i.e. 4A, 4B and 4C. 
Exon 1 were excluded. At 60 °C annealing temperature 
and 40 PCR cycles, the HRM result of amplicon 2, 3, 
4B and 4C showed a crossing point less than cycle 30th 
and single peak of melting curve (Fig. 1A). Clear bands 
matched with the estimated PCR product sizes were 
seen in the agarose gel. However, double peaks of melt-
ing curve (Fig. 1B) and double bands on the agarose gel 
(Fig. 1C) were seen for amplicon 4A and 4C.
 In order to get better HRM curves which represent 
correct product for amplicon 4A and 4C, we modifi ed 
the annealing temperature and number of PCR cycle. 
For amplicon 4A, we tried to increase the temperature 
to 62 °C and 40 cycles. Although the PCR result showed 
one correct band in gel electrophoresis, the relative thin 
band and the amplifi cation curve pattern (Fig. 2) indi-
cated that PCR could be further optimized. PCR with 
temperature 62 °C and 45 cycles produced better results, 
i.e. the amplifi cation curve increased after the 30th cycle 
(Fig. 3A), a single peak of melting curve (Fig. 3B), and a 
thick band matched with the estimated PCR product size 
was seen in the agarose gel (Fig. 3C). However, a smear 
was seen at the upper end of the estimated PCR product 
size. Further increasing the temperature to 63 °C and 50 
cycles resulted in no amplifi cation in the raw material of 
qPCR-HRM (data not shown). 
 Optimization of amplicon 4C was done with higher 
annealing temperature and PCR cycle than that in Fig. 2, 
i.e. 63 °C and 50 times, respectively. This condition re-
sulted in an increase of amplifi cation curve after the 30th 
cycle (Fig. 4A), a single peak of melting curve (Fig. 4B), 
and a clear single band matched with the estimated PCR 
product size in the agarose gel (Fig. 4C). 
 The summary of optimum qPCR-HRM condition of 
amplicons 2, 3, 4A, 4B and 4C are listed in Table 2.
DISCUSSION
It has long been known that the important factors in 
the optimization of HRM technique for genetic variant 
screening are a suitable procedure of the DNA isolation 
and quantifi cation, primer design and an estimated PCR 
product size,13 and data from this study clearly supports 
the idea that appropriate annealing temperature and 
PCR cycles were also important factors in optimization 
of HRM technique for variant screening in APOA1.
 The primers covering exons 2, 3 and 4 were de-
signed using a well-established software, the Lightcycler 
Primer Design Software V.1.0.R.84 (Idaho Tech). The 
maximum PCR product size was 327 bps in exon 4B 
which was qualified for maximum PCR product size 
to achieve 100% sensitivity and 100% specifi city of the 
HRM technique.1, 13 The primers of amplicons 2 and 3 
were ideal primers with PCR product sizes of less than 
250 bps,13 while the size of amplicons 4A and 4C were 
290 bps and 273 bps, respectively. These primer designs 
and the estimated PCR product size were clearly im-
portant in the optimization of PCR-HRM technique for 
variant screening in APOA1. In addition to target length, 
primer sequences should be carefully checked for known 
polymorphisms. Failed identifi cation of any SNP in the 
primer sequence will reduce the success rate of HRM 
analysis since the HRM melting profi le is infl uenced by 
DNA heterozygosity.1–3
 Initially, the experiment used annealing temperature 
60 °C and 40 PCR cycles and it showed that amplicons 
2, 3, 4B and 4C have crossing points of less than 30 (Fig. 
1A). It means that the sample was adequate and the am-
plifi cation was effi cient.13 On the other hand, amplicon 
4A had a crossing point more than 30 cycles, meaning 
that the sample may not be adequate and the amplifi-
cation may not efficient.13 Amplicons 4A and 4C had 
double bands on agarose gel. These could be caused by 
unspecifi c PCR products, and thus required an increase 
in annealing temperature to obtain optimal qPCR-HRM 
conditions. Other possible causes for results of amplicon 
4A which had a crossing point more than 30, double 
peak melting curve and double band on agarose gel were 
less effi cient DNA amplifi cation, a low annealing tem-
perature leading to unspecifi c PCR products, and a CG 
rich content (60.3%) in the DNA sequence.13
 As shown in Fig. 2, an annealing temperature of 62 
°C and 40 PCR cycles also failed to show an optimal 
condition for amplicon 4C. Thus, further increases of 
annealing temperature and PCR cycle, i.e. 63 °C and 
50 cycles were performed to get a single peak of HRM 
curve and single band on agarose gel (Fig. 4). 
 Although a single peak of HRM curve could be 
obtained for amplicon 4A by increasing the annealing 
temperature from 60 to 62 °C, the amplifi cation curve 
did not reach a plateau pattern (Fig. 2) suggesting that 
the optimum temperature was obtained but an additional 
PCR cycle was needed. Although a PCR with a tem-
perature of 62 °C and 45 cycles produced better results, 
a thin smear remained at the upper the estimated PCR 
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Fig. 1. The result of optimization of APOA1 using 
annealing temperature 60 °C and 40 times of PCR 
cycles.
(A) qPCR amplification curve of amplicons 2, 3, 
4B and 4C showed crossing point less than 30, 
while amplicon 4A showed that of more than 30. 
(B) HRM curve of amplicons 2, 3 and 4B had sin-
gle peak, while amplicon 4A and 4C had double 
peak of melting. (C) Amplicons 2, 3 and 4B had 
clear single band on the agarose gel matched with 
the estimated PCR product size, but amplicons 4A 
and 4C had nonspecifi c band; the temperature of 
qPCR was set for starting at 65 °C. bp, base pair; 
dT/dF, delta temperature per delta fl uorescence; H, 
H2O; HRM, high resolution melting; M, molecular 
weight marker; qPCR, quantitative polymerase 
chain reaction; 2, 3, 4A, 4B, and 4C are names of 
amplicons.
Fig. 2. The result of optimization of amplicon 4A 
and 4C APOA1 using annealing temperature 62 °C 
and 40 times of PCR cycles.
(A) qPCR amplifi cation curve of amplicons 4A and 
4C showed crossing point more than 30. (B) HRM 
curve of amplicons 4A and 4C had single peak of 
melting. (C) Amplicon 4A had clear single band on 
the agarose gel matched with the estimated PCR 
product size, but amplicon 4C had a nonspecific 
band. bp, base pair; dT/dF, delta temperature per 
delta fl uorescence; H, H2O; HRM, high resolution 
melting; M, molecular weight marker; qPCR, 
quantitative polymerase chain reaction; 4A and 4C 
are names of amplicons.
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Fig. 4. The result of optimization of amplicon 4C 
APOA1 using annealing temperature 63 °C and 50 
times of PCR cycles.
(A) qPCR amplification curve of the amplicon 4C 
showed crossing point more than 30. (B) Its HRM 
curve had single peak of melting. (C) The amplicon 
had a clear single band on the agarose gel matched 
with the estimated PCR product size. bp, base pair; 
dT/dF, delta temperature per delta fluorescence; H, 
H2O; HRM, high resolution melting; M, molecular 
weight marker; qPCR, quantitative polymerase 
chain reaction; 4A is a name of an amplicon.
Fig. 3. The result of optimization of amplicon 4A 
APOA1 using annealing temperature 62 °C and 45 
times of PCR cycles.
(A) qPCR amplification curve of the amplicons 
showed that amplification was started at the 30th 
cycle. (B) Its HRM curve had single peak of melt-
ing. (C) The amplicon had a clear single band on 
the agarose gel matched with the estimated PCR 
product size, with very thin smear at the upper of 
the correct band. bp, base pair; dT/dF, delta tem-
perature per delta fluorescence; H, H2O; HRM, high 
resolution melting; M, molecular weight marker; 
qPCR, quantitative polymerase chain reaction; 4A is 
a name of an amplicon.
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product size (Fig. 3), and further increasing of tempera-
ture to 63 °C and 50 cycles resulted in no amplification 
detected in the raw material of qPCR-HRM. Thus, at 
this point, considering that the amplification curve after 
the 30th cycle and a single peak of the melting curve 
could be achieved by using an annealing temperature of 
62 °C and 45 cycles, this method could be accepted.  
 Our results indicated that there are primers which 
have similar PCR conditions for HRM, and thus facil-
itate multiple primers for a qPCR-HRM running. In 
contrast, some primers may need different conditions to 
achieve optimum conditions as in APOA1. To evaluate 
whether methods of APOA1 variant screening showed 
in this study are appropriate for detection of mutant 
APOA1, further qPCR-HRM analysis using either ge-
nomic DNA or plasmid DNA harboring APOA1 muta-
tion is warranted. 
 In conclusion, in addition to a suitable procedure 
of DNA isolation and quantification, primer design and 
an estimated PCR product size, the data in this study 
showed that appropriate annealing temperature and PCR 
cycle were important factors in optimization of HRM 
technique for variant screening in APOA1.
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Table 2. Profile of qPCR-HRM of APOA1 
Amplicon Program Temperature (°C) Time Cycle
2, 3 and 4B Initial denaturation 95 5 min 1
Denaturation 95 10 s
Annealing 60 10 s 40
Elongation 72 10 s
HRM 65–95 oC, 0.1 oC temperature increment
1
Wait for 2 s for each steps afterwards
HRM final step 40 1 min 1
4A Initial denaturation 95 5 min 1
Denaturation 95 10 s
Annealing 62 20 s 45
Elongation 72 30 s
HRM 65–95 oC, 0.1 oC temperature increment
1
Wait for 2 s for each steps afterwards
HRM final step 40 1 min 1
4C Initial denaturation 95 5 min 1
Denaturation 95 10 s
Annealing 63 10 s 50
Elongation 72 10 s
HRM 65–95 oC, 0.1 oC temperature increment
1
Wait for 2 s for each steps afterwards
HRM final step 40 1 min 1
HRM, high resolution melting; qPCR, quantitative polymerase chain reaction.
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